SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...

“Our ability to provide our customers with remote feature updates exemplifies our Company’s mission to improve the lives of people with diabetes through relentless innovation and revolutionary ...

Tandem Diabetes Care launched a new predictive feature designed to help reduce the frequency and duration of low-glucose events by pausing insulin delivery. The technology is available as a free ...

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today commenced shipments of t:slim Pumps featuring enhanced software.

An update is available for Tandem’s t:connect iOS mobile app that should prevent it from prematurely draining insulin pump batteries. An update is available for Tandem’s t:connect iOS mobile app that ...

Tandem Diabetes Care ($TNDM), the maker of the t:slim insulin pump, has partnered with open-source software provider Tidepool. The deal is expected to better enable ...

The technology went through the FDA’s new interoperability pathway, which encourages device-makers to build products that can be used across systems or platforms. Both Tandem Diabetes’ software and ...

CHICAGO, Dec 13 (Reuters) - The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's TNDM.O software program that uses readings from a continuous glucose monitor to ...

At least 224 diabetes patients have been harmed by a software error causing their insulin pumps to spontaneously shut down, the Food and Drug Administration announced ...

More than 200 people with diabetes were injured when their insulin pumps shut down unexpectedly due to a problem with a connected mobile app, the US Food and Drug Administration said Wednesday.

A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 ...